openPR Logo
Press release

Rabeprazole Sodium Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029

01-13-2023 05:00 PM CET | Health & Medicine

Press release from: Orion Market Research

Rabeprazole Sodium Market Trends, Research Report, Growth,

During the forecast period, the global rabeprazole sodium market is expected to rise at a considerable CAGR. The market growth is being driven by the rising prevalence rate of gastroesophageal reflux diseases (GERD), duodenal ulcers, and other gut-related infections and diseases globally, which has surged the demand for better treatment options. As per the World Gastroenterology Organization, the prevalence rate of GERD is growing rapidly across the world. It was valued at approximately 2.5%-6.6% in South East Asia and almost 13.8%-25.8% in North America. Moreover, in 2019, the global prevalence of duodenal or peptic ulcer prevalence was approximately 8.09 million representing a 25.82% increase from 1990. The increase in the number of cigarette smokers, alcohol/tobacco consumers, and a significant increase in food habits are the major cause of these diseases. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives but also extends to the healthcare system and economy.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/rabeprazole-sodium-market

The prominent players in the market are focusing on acquisition and partnership collaboration with other market players to broaden their product offering in order to fulfill the growing market demand. For instance, in December 2021, Pfizer Inc. acquired Arena Pharmaceuticals, Inc along with its all the outstanding shares for $100 per share in an all-cash transaction for a total equity value of approximately $6.7 billion, via a definitive agreement. Through this acquisition, the company acquired Arena's portfolio which includes diverse and promising development-stage therapeutic candidates in gastroenterology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a range of immuno-inflammatory diseases including gastrointestinal and dermatological diseases.

Market Coverage

• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
Segment Covered-
• By Type
• By Application
Regions Covered-
• North America
• Europe
• Asia-Pacific
• Rest of the World
Competitive Landscape- including ASN Co., Intas Pharmaceutical Ltd., Pfizer Inc., Sandoz Inc. (Novartis International AG)), Teva Pharmaceutical Industries Ltd., and others.?

Key questions addressed by the report

• What is the market growth rate?
• That segment and region dominate the market in the base year?
• That segment and region will project the fastest growth in the market?
• How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Rabeprazole Sodium Market Report Segment

By Type

• Rabeprazole Sodium Monohydrate
• Rabeprazole Sodium Crystalline

By Application

• Gastroesophageal Reflux Disease Treatment
• Duodenal Ulcer Treatment
• Others

A full report of Rabeprazole Sodium Market is available at: https://www.omrglobal.com/industry-reports/rabeprazole-sodium-market

Rabeprazole Sodium Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• including ASN Co.
• Intas Pharmaceutical Ltd.
• Pfizer Inc.
• Sandoz Inc. (Novartis International AG))
• Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

https://www.asiatimeskorea.com/press-release/%eb%9d%bc%eb%b2%a0%ed%94%84%eb%9d%bc%ec%a1%b8-%eb%82%98%ed%8a%b8%eb%a5%a8-%ec%8b%9c%ec%9e%a5-%eb%8f%99%ed%96%a5-%ec%97%b0%ea%b5%ac-%eb%b3%b4%ea%b3%a0%ec%84%9c-%ec%84%b1%ec%9e%a5-%ea%b8%b0%ed%9a%8c/231732/

https://www.diario-ya.com/regionales/%e7%9b%90%e9%85%b8%e9%98%bf%e8%8e%ab%e7%bd%97%e8%8a%ac%e5%b8%82%e5%9c%ba%e8%a7%84%e6%a8%a1%e3%80%81%e4%bb%bd%e9%a2%9d%e3%80%81%e8%a1%8c%e4%b8%9a%e5%a2%9e%e9%95%bf%e3%80%81%e5%88%86%e6%9e%90%e5%92%8c/311640/

https://sportmsr.com/2029-%d9%86%d9%85%d9%88-%d8%b3%d9%88%d9%82-%d8%b9%d9%84%d8%a7%d8%ac-%d8%a7%d9%84%d9%86%d8%a7%d8%b3%d9%88%d8%b1-%d8%a7%d9%84%d8%b4%d8%b1%d8%ac%d9%8a-%d8%8c-%d8%ad%d8%b5%d8%a9-%d8%8c-%d8%a7%d8%aa%d8%ac/

https://monblogapple.com/2023/01/09/taille-part-croissance-analyse-et-previsions-du-marche-des-hormones-animales-2023-2029/

https://citytoday-hildesheim.de/index.php/2023/01/09/squalen-aus-tierischen-quellen-marktanteil-trends-analyse-und-prognose-2023-2029/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rabeprazole Sodium Market Trends, Research Report, Growth, Opportunities and Forecast 2023-2029 here

News-ID: 2883173 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Rabeprazole

Rabeprazole Sodium Market Analysis Current Landscape and Future Outlook
The global Rabeprazole Sodium market was valued at approximately USD 681.2 million in 2024 and is projected to reach around USD 920 million by 2033, growing at a compound annual growth rate (CAGR) of about 3.5% from 2025 to 2033. Rabeprazole Sodium Market Overview The Rabeprazole Sodium market is driven by the rising prevalence of gastrointestinal disorders such as GERD, peptic ulcers, and Zollinger-Ellison syndrome, which are increasingly common due to changing
Rabeprazole Sodium Market Size, Growth Drivers, and Competitive Landscape.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Application (Gastroesophageal Reflux Disease, Peptic Ulcer, Others), By Age (Below 55 Years, Above 55 Years), By Distribution Channel (Hospital Pharmacies, Drug And Retail Store Pharmacies, Online Providers)- Market Outlook And Industry Analysis 2031" The global rabeprazole sodium market is estimated to reach over USD 923.72
Rabeprazole Sodium Market: Size, Share, Growth, Analysis, Key Players, Revenue, …
Rabeprazole Sodium Market Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach. The global Rabeprazole Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast
Rabeprazole Sodium Market Size Estimated to Observe Significant Growth by 2031
The Rabeprazole Sodium Market is a significant segment within the pharmaceutical industry, specializing in medications containing rabeprazole sodium, a proton pump inhibitor (PPI) commonly prescribed to manage acid-related gastrointestinal conditions. Rabeprazole sodium is used in the treatment of disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. This market has experienced steady growth due to the increasing prevalence of acid-related disorders and the effectiveness of rabeprazole sodium
Rabeprazole Sodium Market expected to Witness Huge Revenue Growth to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Application (Gastroesophageal Reflux Disease, Peptic Ulcer, Others), By Age (Below 55 Years, Above 55 Years), By Distribution Channel (Hospital Pharmacies, Drug And Retail Store Pharmacies, Online Providers)- Market Outlook And Industry Analysis 2031". The Global Rabeprazole Sodium Market Size is valued at 640.89 million in 2022
Rabeprazole Sodium Market Research Report
Rabeprazole Sodium is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori bacterial infections in the stomach. The global Rabeprazole Sodium market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029.